| Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer O Saatci, A Kaymak, U Raza, PG Ersan, O Akbulut, CE Banister, ... Nature communications 11 (1), 2416, 2020 | 221 | 2020 |
| miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance M Mutlu, U Raza, Ö Saatci, E Eyüpoğlu, E Yurdusev, Ö Şahin Journal of Molecular Medicine 94, 629-644, 2016 | 140 | 2016 |
| Polyol pathway links glucose metabolism to the aggressiveness of cancer cells A Schwab, A Siddiqui, ME Vazakidou, F Napoli, M Böttcher, B Menchicchi, ... Cancer research 78 (7), 1604-1618, 2018 | 101 | 2018 |
| MicroRNAs: master regulators of drug resistance, stemness, and metastasis U Raza, JD Zhang, Ö Şahin Journal of molecular medicine 92, 321-336, 2014 | 88 | 2014 |
| miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer M Mutlu, Ö Saatci, SA Ansari, E Yurdusev, H Shehwana, Ö Konu, U Raza, ... Scientific reports 6 (1), 32541, 2016 | 71 | 2016 |
| Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer Ö Saatci, S Borgoni, Ö Akbulut, S Durmuş, U Raza, E Eyüpoğlu, C Alkan, ... Oncogene 37 (17), 2251-2269, 2018 | 68 | 2018 |
| The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer U Raza, Ö Saatci, S Uhlmann, SA Ansari, E Eyüpoğlu, E Yurdusev, ... Oncotarget 7 (31), 49859, 2016 | 61 | 2016 |
| Pathobiology of Pulmonary Artery Hypertension: Role of lncRNAs KR Zahid, U Raza, J Chen, JU Raj, Gou, Deming Cardiovascular Research, 2020 | 50 | 2020 |
| Reactivation of cAMP pathway by PDE4D inhibition represents a novel druggable axis for overcoming tamoxifen resistance in ER-positive breast cancer RR Mishra, N Belder, SA Ansari, M Kayhan, H Bal, U Raza, PG Ersan, ... Clinical Cancer Research 24 (8), 1987-2001, 2018 | 48 | 2018 |
| Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases Y Jin, W Wang, Q Wang, Y Zhang, KR Zahid, U Raza, Y Gong Cancer cell international 22 (1), 156, 2022 | 25 | 2022 |
| mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silico KR Zahid, S Yao, ARR Khan, U Raza, D Gou Frontiers in oncology 9, 1000, 2019 | 25 | 2019 |
| Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer R Assidicky, UM Tokat, IO Tarman, O Saatci, PG Ersan, U Raza, H Ogul, ... Breast cancer research and treatment 193 (2), 331-348, 2022 | 24 | 2022 |
| Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death KR Zahid, S Han, F Zhou, U Raza Cellular Oncology 42, 55-66, 2019 | 16 | 2019 |
| Neutrophils: Musketeers against Immunotherapy KR Zahid, U Raza, S Tumbath, L Jiang, W Xu, X Huang Frontiers in Oncology, 4415, 2022 | 13 | 2022 |
| SIRT7: The seventh key to unlocking the mystery of aging U Raza, X Tang, Z Liu, B Liu Physiological Reviews, 2023 | 9 | 2023 |
| KIN17 promotes tumor metastasis by activating EMT signaling in luminal‐A breast cancer Q Huang, KR Zahid, J Chen, X Pang, M Zhong, H Huang, W Pan, J Yin, ... Thoracic Cancer 12 (13), 2013-2023, 2021 | 9 | 2021 |
| Systems biology based meth-miRNA–mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and … KR Zahid, M Su, ARR Khan, S Han, G Deming, U Raza Cancer cell international 19, 1-16, 2019 | 6 | 2019 |
| MIR200C (microRNA 200c) M Mutlu, Ö Saatçi, U Raza, E Eyüpoglu, E Yurdusev, Ö Sahin Atlas Genet Cytogenet Oncol Haematol 19, 270-285, 2015 | 5 | 2015 |
| KIN17 promotes cell migration and invasion through stimulating the TGF-β/Smad2 pathway in hepatocellular carcinoma TZ Zichang Dai,Qiyuan Huang,Xueran Huang,Chuiyu Zhu,Kashif Rafiq Zahid ... molecular carcinogenesis, 2022 | 3* | 2022 |
| Benign Adult Brain Tumors and Pediatric Brain Tumors S Yao, U Raza, F Akter Neuroscience for Neurosurgeons, 214, 2023 | | 2023 |
